Winner
Corporate Affairs at Takeda UK
Summary of work
Takeda’s External Affairs team adeptly tackled 2024’s unique challenges, strengthening our position amidst substantial reputational hurdles, governmental changes, national pricing complexities, and deteriorating employee well-being. Central to our approach was placing patients at the forefront while focusing on internal and external collaboration. We controlled risks while boldly advancing campaigns and partnerships. Recognising the vital role we play in shaping organisational culture, we promoted a growth mindset and prioritised employee well-being, resulting in significant progress.
Our agile approach empowered team members as subject matter experts, leveraging collaborations to enhance our reach. This facilitated major gains, including an elevated media presence, trusted adviser status with stakeholders, policy exemptions that supported our business and increased employee satisfaction. By supporting and learning from one another, we united to put External Affairs at the core of our business whilst maintaining a steadfast focus on the patient.
By aligning our efforts with Takeda’s strategic goals, we elevated our organisational and industry impact, advocating for patient communities, whilst safeguarding our reputation. These strategies affirmed our commitment to driving positive change and set the groundwork for continued growth. Our efforts exemplified innovation and resilience, positioning Takeda as an industry leader and pioneer in fostering a progressive organisational culture.
Judges’ comments
Takeda’s External Affairs team delivered exceptional work in what was clearly a uniquely challenging year for the company, and demonstrated that comms should be at the table in every discussion. With just 11 people and a relatively low budget, the team acted on its responsibility to educate and collaborate with patient groups. Its bravery and transparency in addressing difficult situations, such as launching a patient activation campaign following a supply issue, is indicative of its unwavering commitment to patients.
